Warning Letter — pouchline.com
The FDA Center for Tobacco Products issued a warning letter to the website pouchline.com following enforcement activities related to the sale of unauthorized tobacco products.
This affects operators of tobacco-related e-commerce websites and firms involved in the online distribution of nicotine pouch products.
The issuance of this letter by the Center for Tobacco Products suggests continued oversight of online retailers selling nicotine-containing items. Regulatory teams should interpret this as a signal that the FDA is prioritizing the removal of unauthorized or misbranded nicotine products from digital marketplaces, even for entities that may primarily serve as third-party distributors.
Review e-commerce platform inventory for products lacking valid marketing authorization and ensure marketing claims do not exceed authorized labeling. Verify that all nicotine-containing products listed for sale comply with the FD&C Act requirements for premarket review.
FDA Warning Letter issued to: pouchline.com. 05/19/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pouchlinecom-730123-05192026
Open in openFDA / FDA.gov